Drugs / Infanrix-IPV/Hib
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00307034 Background | Jan 2006 → Jan 2007 | streptococcal infection | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Infanrix-IPV/Hib | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00307034 ↗ |
| Modality | Vaccine | “DTPa-combined vaccine (Infanrix hexa or Infanrix IPV/Hib)” NCT00307034 ↗ |
| Route | Intramuscular | “Intramuscular injection, 3 doses (2-4-11 months of age schedule).” NCT00307034 ↗ |